List view / Grid view
The consortium also consists of 10 pharmaceutical companies and five…
The consortium also consists of 10 pharmaceutical companies and five organisations to accelerate gene therapies to treat rare diseases.
The adaptive ACTIV-5/BET study will test two monoclonal antibody therapies…
The adaptive ACTIV-5/BET study will test two monoclonal antibody therapies in hospitalised COVID-19 patients to establish if they warrant larger clinical trials.
Operation Warp Speed and the NIH are funding the expansion…
Operation Warp Speed and the NIH are funding the expansion of two trials evaluating the efficacy of convalescent plasma therapy in hospitalised COVID-19 patients.
The adaptive Phase III trials will assess whether various types…
The adaptive Phase III trials will assess whether various types and doses of blood thinners can prevent COVID-19 patients forming potentially fatal blood clots.
